Literature DB >> 5972523

Mechanisms determining the behaviour of the left atrial pressure during cardioplegia.

J B Johnston, G R Pritchard, J S Wright.   

Abstract

Mesh:

Year:  1966        PMID: 5972523      PMCID: PMC1019110          DOI: 10.1136/thx.21.6.551

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  7 in total

1.  CLINICAL EXPERIENCE WITH A CLOSED-CHEST METHOD OF PRODUCING PROFOUND HYPOTHERMIA AND TOTAL CIRCULATORY ARREST IN NEUROSURGERY.

Authors:  J D MICHENFELDER; J W KIRKLIN; A UIHLEIN; H J SVIEN; C S MACCARTY
Journal:  Ann Surg       Date:  1964-01       Impact factor: 12.969

2.  STUDIES OF LEFT ATRIAL PRESSURE DURING CARDIOPLEGIA PRODUCED BY PROFOUND HYPOTHERMIA USING THE CLOSED CHEST TECHNIQUE.

Authors:  J B JOHNSTON; J M NIELD; G R PRITCHARD; V M HERCUS
Journal:  Thorax       Date:  1965-05       Impact factor: 9.139

3.  PROFOUND HYPOTHERMIA FOR INTRACRANIAL SURGERY: CASE REPORT.

Authors:  A GONSKI; J B JOHNSTON; V M HERCUS; R A ROLLISON; J NIELD
Journal:  Med J Aust       Date:  1964-02-29       Impact factor: 7.738

4.  Craniotomy under conditions of quinidine-protected cardioplegia and profound hypothermia.

Authors:  B WOODHALL; W C SEALY; K D HALL; W L FLOYD
Journal:  Ann Surg       Date:  1960-07       Impact factor: 12.969

5.  Transeptal left heart catheterization: a new method of left atrial puncture.

Authors:  J ROSS
Journal:  Ann Surg       Date:  1959-03       Impact factor: 12.969

6.  Elective cardiac arrest during total body perfusion: the relationship of elevated intracardiac pressures during arrest to subsequent myocardial function and pathologic pulmonary changes.

Authors:  J ROSS; J W GILBERT; E H SHARP; A G MORROW
Journal:  J Thorac Surg       Date:  1958-10

7.  Profound hypothermia for intracranial surgery: laboratory and clinical experiences with extracorporeal circulation by peripheral cannulation.

Authors:  R H PATTERSON; B S RAY
Journal:  Ann Surg       Date:  1962-09       Impact factor: 12.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.